Utility of 18F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours
Adult
Male
Submandibular Gland
Middle Aged
Salivary Gland Neoplasms
Multimodal Imaging
3. Good health
Sublingual Gland
03 medical and health sciences
0302 clinical medicine
Fluorodeoxyglucose F18
Positron-Emission Tomography
Image Processing, Computer-Assisted
Humans
Parotid Gland
Female
Radiopharmaceuticals
Tomography, X-Ray Computed
Aged
Neoplasm Staging
Retrospective Studies
Ultrasonography
DOI:
10.1097/mnm.0b013e32835bc4c4
Publication Date:
2012-12-12T07:53:41Z
AUTHORS (9)
ABSTRACT
The aim of this study was to evaluate the clinical utility (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography-computed tomography (PET-CT) in staging and restaging patients with malignant primary salivary gland tumours.Data pertaining 30 (age: 43.8±16.8 years; male/female: 20/10) histopathologically proven tumours who underwent 36 F-FDG PET-CTs were retrospectively analysed. Ten performed for 26 restaging. site parotid 22 patients, submandibular seven minor one patient. (18)F-FDG PET-CT images revaluated by two nuclear medicine physicians consensus. Findings grouped into local disease, nodal disease distant metastasis. Results compared those conventional imaging modalities [CIM (CT/ultrasound/bone scintigraphy)] when available (n=28). Clinical or follow-up (minimum 6 months) data along histopathological information (when available) taken as reference standard.Overall, 25 positive 11 negative disease. showed 21 17 metastasis nine (lungs, four; liver, three; bones, thyroid, one). Twenty-three true positive, negative, false negative. overall sensitivity 92%, specificity 82%, predictive value 82% accuracy 89%. No significant difference seen between groups (100 vs. 85%; P=0.468). In whom comparable CIM (n=28), did not show any advantage over (P=0.012) but more specific (71 43%).(18)F-FDG shows high tumours. It is than purpose.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....